Tailored circulatory intervention in adults with pulmonary hypertension due to congenital heart disease

被引:0
作者
Couperus, L. E. [1 ]
Henkens, I. R. [1 ]
Jongbloed, M. R. M. [1 ,2 ]
Hazekamp, M. G. [3 ]
Schalij, M. J. [1 ]
Vliegen, H. W. [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Anat, Leiden, Netherlands
[3] Leiden Univ, Med Ctr, Dept Cardiothorac Surg, Leiden, Netherlands
关键词
Pulmonary hypertension; Congenital heart defects; Right ventricular dysfunction; Intervention; PATENT DUCTUS-ARTERIOSUS; ATRIAL SEPTAL-DEFECT; EISENMENGER-SYNDROME; THERAPY; PERSPECTIVE; SEPTOSTOMY; SURVIVAL; CLOSURE; AGE;
D O I
10.1007/s12471-016-0833-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Adults with pulmonary hypertension associated with congenital heart disease (PH-CHD) often have residual shunts. Invasive interventions aim to optimise pulmonary flow and prevent right ventricular failure. However, eligibility for procedures strongly depends on the adaptation potential of the pulmonary vasculature and right ventricle to resultant circulatory changes. Current guidelines are not sufficiently applicable to individual patients, who exhibit great diversity and complexity in cardiac anomalies. Methods and Results We present four complex adult PH-CHD patients with impaired pulmonary flow, including detailed graphics of the cardiopulmonary circulation. All these patients had an ambiguous indication for shunt intervention. Our local multidisciplinary Grown-Ups with Congenital Heart Disease team reached consensus regarding a patient-tailored invasive treatment strategy, adjacent to relevant guidelines. Interventions improved pulmonary haemodynamics and short-term clinical functioning in all cases. Conclusions Individual evaluation of disease characteristics is mandatory for tailored interventional treatment in PH-CHD patients, adjacent to relevant guidelines. Both strict registration of cases and multidisciplinary and multicentre collaboration are essential in the quest for optimal therapy in this patient population.
引用
收藏
页码:400 / 409
页数:10
相关论文
共 27 条
[1]   Atrial septostomy for pulmonary arterial hypertension [J].
Allcock, RJ ;
O'Sullivan, JJ ;
Corris, PA .
HEART, 2003, 89 (11) :1344-1347
[2]   ESC Guidelines for the management of grown-up congenital heart disease (new version 2010) [J].
Baumgartner, Helmut ;
Bonhoeffer, Philipp ;
De Groot, Natasja M. S. ;
de Haan, Fokko ;
Deanfield, John Erik ;
Galie, Nazzareno ;
Gatzoulis, Michael A. ;
Gohlke-Baerwolf, Christa ;
Kaemmerer, Harald ;
Kilner, Philip ;
Meijboom, Folkert ;
Mulder, Barbara J. M. ;
Oechslin, Erwin ;
Oliver, Jose M. ;
Serraf, Alain ;
Szatmari, Andras ;
Thaulow, Erik ;
Vouhe, Pascal R. ;
Walma, Edmond .
EUROPEAN HEART JOURNAL, 2010, 31 (23) :2915-2957
[3]   Predictors of pregnancy complications in women with congenital heart disease [J].
Drenthen, Willem ;
Boersma, Eric ;
Balci, Ali ;
Moons, Philip ;
Roos-Hesselink, Jolien W. ;
Mulder, Barbara J. M. ;
Vliegen, Hubert W. ;
van Dijk, Arie P. J. ;
Voors, Adriaan A. ;
Yap, Sing C. ;
van Veldhuisen, Dirk J. ;
Pieper, Petronella G. .
EUROPEAN HEART JOURNAL, 2010, 31 (17) :2124-2132
[4]   Pulmonary arterial hypertension in congenital heart disease: An epidemiologic perspective from a Dutch registry [J].
Duffels, M. G. J. ;
Engelfriet, P. M. ;
Berger, R. M. F. ;
van Loon, R. L. E. ;
Hoendermis, E. ;
Vriend, J. W. J. ;
van der Velde, E. T. ;
Bresser, P. ;
Mulder, B. J. M. .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2007, 120 (02) :198-204
[5]  
Eicken Andreas, 2007, Int J Cardiol, V117, pe40, DOI 10.1016/j.ijcard.2006.10.023
[6]   Reversal of pulmonary hypertension and subsequent repair of atrial septal defect after treatment with continuous intravenous epoprostenol [J].
Frost, AE ;
Quiñones, MA ;
Zoghbi, WA ;
Noon, GP .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (04) :501-503
[7]   Pulmonary arterial hypertension in paediatric and adult patients with congenital heart disease [J].
Gatzoulis, M. A. ;
Alonso-Gonzalez, R. ;
Beghetti, M. .
EUROPEAN RESPIRATORY REVIEW, 2009, 18 (113) :154-161
[8]   Longer-term bosentan therapy improves functional capacity in Eisenmenger syndrome:: Results of the BREATHE-5 open-label extension study [J].
Gatzoulis, Michael A. ;
Beghetti, Maurice ;
Galie, Nazzareno ;
Granton, John ;
Berger, Rolf M. F. ;
Lauer, Andrea ;
Chiossi, Eleonora ;
Landzberg, Michael .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2008, 127 (01) :27-32
[9]   Continuous Epoprostenol Therapy and Septal Defect Closure in a Patient With Severe Pulmonary Hypertension [J].
Hirabayashi, Aki ;
Miyaji, Katsumasa ;
Akagi, Teiji .
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2009, 73 (05) :688-691
[10]   Eisenmenger Syndrome: Not Always Inoperable [J].
Huang, Jing-Bin ;
Liang, Jian ;
Zhou, Li-Yan .
RESPIRATORY CARE, 2012, 57 (09) :1488-1495